← FDA DRUG APPROVALS

FDA ANDA · ANDA085825

TRIAMCINOLONE ACETONIDE

Sponsor: WATSON LABS

APPLICATION
ANDA085825
TYPE
ANDA
ORIGINAL APPROVAL
1981-11-05
LATEST ACTION
1999-02-19
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

TRIAMCINOLONE ACETONIDEDiscontinued
TRIAMCINOLONE ACETONIDE 40MG/ML · INJECTABLE · INJECTION

Approval history

1999-02-19Manufacturing (CMC) · Supplement 24AP
1999-02-02Manufacturing (CMC) · Supplement 23AP
1998-05-28Manufacturing (CMC) · Supplement 21AP
1990-05-11Manufacturing (CMC) · Supplement 19AP
1990-05-11Manufacturing (CMC) · Supplement 18AP
1989-12-01Manufacturing (CMC) · Supplement 14AP
1989-01-03Manufacturing (CMC) · Supplement 17AP
1988-10-04Labeling · Supplement 15AP
1988-03-02Labeling · Supplement 13AP
1986-07-17Manufacturing (CMC) · Supplement 10AP
1985-02-04Manufacturing (CMC) · Supplement 9AP
1983-02-14Manufacturing (CMC) · Supplement 5AP
1982-12-27Manufacturing (CMC) · Supplement 4AP
1982-12-27Manufacturing (CMC) · Supplement 3AP
1982-03-19Manufacturing (CMC) · Supplement 1AP
1981-11-05OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →